Andrew Humberstone

Nucleus Network Ltd. engages in the ownership and operation of a clinical research organization. It offers product development consultation services, including regulatory strategy, pre-clinical gap analysis, and preparation of clinical trial documentation as well as provides regulatory submission services for clinical trials and marketing authorization applications. The firm also provides education services such as GCP education, classroom courses, seminars, certification reviews, certification review packages, online courses, resources and standard operating procedures related education services. The company was founded by Garry Jennings in 2003 and is headquartered in Melbourne, Australia.